Literature DB >> 25196966

Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.

Christine C Siska1, Christopher J Pierini, Hollis R Lau, Ramil F Latypov, R Matthew Fesinmeyer, Jennifer R Litowski.   

Abstract

Polysorbate 20 (PS20) is a nonionic surfactant frequently used to stabilize protein biopharmaceuticals. During the development of mAb formulations containing PS20, small clouds of particles were observed in solutions stored in vials. The degree of particle formation was dependent on PS20 concentration. The particles were characterized by reversed-phase HPLC after dissolution and labeling with the fluorescent dye 1-pyrenyldiazomethane. The analysis showed that the particles consisted of free fatty acids (FFAs), with the distribution of types consistent with those found in the PS20 raw material. Protein solutions formulated with polysorbate 80, a chemically similar nonionic surfactant, showed a substantial delay in particle formation over time compared with PS20. Multiple lots of polysorbates were evaluated for FFA levels, each exhibiting differences based on polysorbate type and lot. Polysorbates purchased in more recent years show a greater distribution and quantity of FFA and also a greater propensity to form particles. This work shows that the quality control of polysorbate raw materials could play an important role in biopharmaceutical product quality.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  HPLC (high-performance/pressure liquid chromatography); IgG antibody; excipients; formulation; mAb; particle size; protein formulation; surfactants

Mesh:

Substances:

Year:  2014        PMID: 25196966     DOI: 10.1002/jps.24144

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

2.  Degradation Mechanisms of Polysorbate 20 Differentiated by 18O-labeling and Mass Spectrometry.

Authors:  Lin Zhang; Sandeep Yadav; Barthélemy Demeule; Y John Wang; Olivier Mozziconacci; Christian Schӧneich
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

3.  A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.

Authors:  Nidhi Doshi; Jamie Giddings; Lin Luis; Arthur Wu; Kyle Ritchie; Wenqiang Liu; Wayman Chan; Rosalynn Taing; Jeff Chu; Alavattam Sreedhara; Aadithya Kannan; Pervina Kei; Ian Shieh; Tobias Graf; Mark Hu
Journal:  Pharm Res       Date:  2021-03-12       Impact factor: 4.200

4.  Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation.

Authors:  Nidhi Doshi; Kyle Ritchie; Tamanna Shobha; Jamie Giddings; Kathrin Gregoritza; Rosalynn Taing; Stephen Rumbelow; Jeff Chu; Anthony Tomlinson; Aadithya Kannan; Miguel Saggu; Si Kai Cai; Victor Nicoulin; Wenqiang Liu; Steve Russell; Lin Luis; Sandeep Yadav
Journal:  Pharm Res       Date:  2021-09-08       Impact factor: 4.200

5.  Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.

Authors:  Ankit D Kanthe; Miriam R Carnovale; Joshua S Katz; Susan Jordan; Mary E Krause; Songyan Zheng; Andrew Ilott; William Ying; Wei Bu; Mrinal K Bera; Binhua Lin; Charles Maldarelli; Raymond S Tu
Journal:  Mol Pharm       Date:  2022-07-26       Impact factor: 5.364

6.  A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions.

Authors:  Aadithya Kannan; Jamie Giddings; Shrenik Mehta; Tiffany Lin; Anthony Tomlinson; Kyle Ritchie; Ian Shieh; Miguel Saggu; Nidhi Doshi
Journal:  Pharm Res       Date:  2022-03-11       Impact factor: 4.200

7.  Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles.

Authors:  Christopher P Calderon; Ana Krhač Levačić; Constanze Helbig; Klaus Wuchner; Tim Menzen
Journal:  J Pharm Sci       Date:  2022-06-01       Impact factor: 3.784

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.